)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
Jaguar Health
Jaguar Health (JAGX) investor relations material
Jaguar Health 2nd Annual Lytham Partners Healthcare Investor Summit summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.2nd Annual Lytham Partners Healthcare Investor Summit summary15 Jan, 2026
Strategic partnerships and licensing
Entered an exclusive license agreement with FuturePak, potentially worth up to $38 million, including $16 million upfront and $20 million in commercial milestones.
FuturePak, through Theratechnologies, will now commercialize Mytesi and Canalevia-CA1, allowing a focus on R&D and pipeline development.
Manufacturing of crofelemer remains in-house, turning it into a profit center.
Business development opportunities remain for blockbuster indications and international animal health markets.
Pipeline and clinical development
Focus shifted to rare disease programs, especially MVID and short bowel syndrome, with clinical trials ongoing.
MVID program may allow for FDA filing by end of this year, with potential approval in 2026 based on single-digit patient trials.
Proof-of-concept data showed up to 39% reduction in parenteral support for MVID and 12-15% for SBS, supporting breakthrough and prime designations.
Short bowel syndrome market estimated at $5–12 billion, with limited competition and high unmet need.
Key milestones include completion of MVID and SBS trials, regulatory filings, and business development deals in 2026.
Regulatory and commercial highlights
Mytesi is the only FDA-approved oral botanical drug for chronic diarrhea in HIV/AIDS and has exclusivity due to botanical guidance.
Canalevia-CA1 received renewed conditional FDA approval for chemotherapy-induced diarrhea in dogs, with a full approval study underway.
Breakthrough and prime designations could accelerate regulatory timelines in the US and EU for rare disease indications.
Investigator-initiated trials and international collaborations are expanding clinical evidence and global reach.
Milestone payments from FuturePak and expanded commercial resources are expected to drive revenue growth.
Crofelemer's competitive edge in SBS market
MVID designation impact on approval timeline
Future of retained blockbuster indications
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Jaguar Health earnings date
Q4 202527 Mar, 2026
Jaguar Health
Next Jaguar Health earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Jaguar Health Inc. is a commercial-stage pharmaceutical company focused on developing plant-based gastrointestinal products. The company targets unmet medical needs in human and animal health through proprietary formulations derived from botanical sources. Its development activities support prescription and non-prescription markets. The company is headquartered in San Francisco, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage